维普中文期刊产品整合服务
102篇 您的检索式:作者名="Tanei"
    题名 作者 年代 出处 被引量
1Prognostic significance of Ki -67 index after neoadjuvant chemotherapy in breast cancer显示文摘Tanei T Shimomura A Shimazu K 2011Eur J Surg Oncol2011,37,2:1
2Transfusion-associated graft-versus-host disease: an in situ hybridization analysis of the infiltrationg donor-derived cells in the cutaneous lesion显示文摘 Ohta Y Ishihara S 1999Dermatology1999,199,:1
3Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers显示文摘TANEI T MORIMOTO K SHIMAZU K 2009Clin Cancer Res2009,15,12:1
4Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 ex- pression with resistance to sequential Paclitaxel and epirubicin based chemotherapy for breast caneers显示文摘Tanei T Morimoto K Shimazu K 2009Clin Cancer Res2009,15,42:1
5Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by nega- tive estrogen receptor, positive human epidermal growth factor re- ceptor type 2, and high Ki67 expression 显示文摘Morimoto K Kim S J Tanei T 2009Cancer Sci2009,100,6:1
6Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers显示文摘Tanei T Morimoto K Shimazu K 0,,12:1
7Transfusion - associates graft -versus- host disease:an in situ hybridization analysis of the infiltrating donnrderived cells in the cutaneous lesion 显示文摘Tanei R Ohta Y Ishihara S 1999Dermatology1999,199,:1
8Atopic dermatitis in the elderly显示文摘Tanei R 2009Inflamm Allergy Drug Targets2009,8,5:1
9Association of breast cancer stem cells identified by aldehyde dehydrogenase I expres- sion with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers 显示文摘Tanei T Morimoto K Shimazu K 2009Clin Cancer Res2009,15,12:1
10Prognostic significanceof Ki67 index after neoadjuvant chemotherapy in breast cancer显示文摘Tanei T Shimomura A Shimazu K 2011Eur J Surg Oncol (EJSO)2011,37,2:1
11The Irritable Bowel Syndrome and Phychiatric Disorder in the coomunity:is Thare a link?显示文摘Taney N J Howell S Poulton R 2001Am J Gastronenteril2001,96,:1
12Clinical and histopathologic analysis of the relationship between lichen planus and chronic hepatitis C显示文摘Tanei R Watanabe K Nishiyama S 1995J Dermatol1995,22,5:1
13The Irritable Bowel Syndrome and Phychiatric Disorder in the Coommunity:is Thare a Link? 显示文摘Taney N J Howell S Poulton R 2001Am J Gastronenteril2001,96,:1
14Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression显示文摘Morimoto H Kim S J Tanei T 2009Cancer Sci2009,100,6:1
15Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer 显示文摘Tanei T Shimomura A Shimazu K 2011Eur J Surg Oncol2011,37,2:1
16Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer显示文摘Tanei T Shimomura A Shimazu K 2011EurJSurgOncol2011,37,2:1
17Survey on cellular phone usage on students in Thailand显示文摘KAWASAKI N TANEI S OGATA F 2006J Physiol Anthropol2006,25,6:1
18Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicinbased chemotherapy for breast cancers显示文摘Tanei T Morimoto K Shimazu K 0,,:1
19Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer显示文摘TANEI T SHIMOMURA A SHIMAZU K 2011Eur J Surg Oncol2011,37,2:1
20Stem cell marker alde- hyde dehydrogenase 1 -positive breast cancers are charac- terized by negative estrogen receptor, positive human epi- dermal growth factor receptor type 2, and high Ki67 expres- sion 显示文摘Morimoto K Kim S J Tanei T 2009Cancer Sci2009,100,6:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费